Photo Credit: Adapted from Perera D. Revascularization in LV systolic dysfunction: revived or dead? Presented at: TCT 2022. Boston, MA. NEW ORLEANS, LA—No matter what the viability testing shows, ...
Bethesda, MD - Establishing the presence or absence of myocardial viability in patients with severe coronary artery disease (CAD) and left ventricular (LV) dysfunction may help to identify those who ...
There is no magical amount of viable ventricular myocardium that makes percutaneous coronary intervention (PCI) an effective addition to optimal medical therapy (OMT) in stable patients with coronary ...
NEW ORLEANS — PCI may not improve survival or left ventricular recovery among patients with ischemic cardiomyopathy compared with optimal medical therapy alone, regardless of baseline myocardial ...
Bioprocessing depends on cells as drug-making factories, and that requires one crucial factor—keeping those cells alive. So, two bioprocessing experts based in New York—Julian Rosenberg, PhD, ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Viable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback